[Ip-health] Clinical Trial waiver granted on SOF+LDV and DAC in India.

Giten Khwairakpam giten.khwairakpam at treatasia.org
Thu Nov 26 23:55:33 PST 2015


The Apex committee under CDSCO in India in its meeting held on 3rd November has granted waiver of Local trial to Both Sofosbuvir and Ledipasvir co-formulation and also daclatasvir.

Let's wait for the drugs!!!!!!! It should hit the markets in two to four weeks. Will share more information soon.


Giten. Khwairakpam
Project Manager, Community and Policy

TREAT Asia/amfAR - The Foundation for AIDS Research
388 Sukhumvit Road, Suite 2104
Klongtoey, Bangkok 10110
t. +66 2 663 7561
f. +66 2 663 7562

More information about the Ip-health mailing list